FIELD: biotechnologies.
SUBSTANCE: invention relates to biotechnology and genetic engineering. Proposed are the mice with reduced or absent activity ADAM6 provided by the endogenous locus ADAM6, or with lack of the endogenous loci encoding the mouse protein ADAM6, the feature of these mice is that they have the sequence encoding ADAM6, or its ortholog, or homologue, or the fragment functional for male mice. According to one version of implementation the said sequence represents ectopic sequence ADAM6 or the sequence making male mice being able to procreate offsprings by mating. Also provided are the mice and the cells with genetically modified loci immunoglobulin heavy chain containing ectopic sequence of nucleotides coding the mouse ADAM6 or its functional fragment, homologue or ortholog.
EFFECT: proposed invention may be used in immunology.
23 cl, 41 dwg, 13 tbl, 11 ex
Title | Year | Author | Number |
---|---|---|---|
ADAM6 MICE | 2012 |
|
RU2722373C2 |
HUMANISED LIGHT CHAIN MICE | 2012 |
|
RU2664181C2 |
MICE WITH HUMANIZED LIGHT CHAIN | 2012 |
|
RU2761639C2 |
HUMANISED UNIVERSAL LIGHT CHAIN MICE | 2012 |
|
RU2664232C2 |
MICE WITH HUMANIZED UNIVERSAL LIGHT CHAIN | 2012 |
|
RU2787781C2 |
HUMANIZED NON-HUMAN ANIMALS WITH RESTRICTED IMMUNOGLOBULIN HEAVY CHAIN LOCI | 2013 |
|
RU2656155C2 |
HUMANIZED GNAWING ANIMALS THAT EXPRESS HEAVY CHAINS CONTAINING V DOMAINS | 2013 |
|
RU2664185C2 |
HUMANIZED RODENTS WHICH EXPRESS HEAVY CHAINS CONTAINING VDOMAINS | 2013 |
|
RU2770016C2 |
NON-HUMAN ANIMALS WITH CONSTRUCTED LIGHT CHAIN OF LAMBDA IMMUNOGLOBULIN, AND THEIR USE | 2018 |
|
RU2778410C2 |
HUMANIZED RODENTS FOR TESTING THERAPEUTIC AGENTS | 2019 |
|
RU2805212C2 |
Authors
Dates
2016-04-20—Published
2012-02-24—Filed